{"ticker": {"uuid": "b34baee9-2ef9-43aa-be22-0e084e0f3c2a", "symbol": "AIDX", "name": "20/20 Biolabs, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxORk9ENlh5SlJsMWUxNEQxVlpSRENmeGxhU0hUdE02bERwWWZRSEZTeWRKZ1BuREhJOUppdTVnV0VjZ0tibGRpa0lzR1h4OXJNM1ZQdjA1YXVJbkZnd3N6U2xGX3hjaFVESWp5RWpQN2tOVG96ZnpCMUhZd0hha3NMZ3Z0Z1pEbHNpM2ZVSEFQQUVIQjFVTGNUUmlFNXhBQ3pmWWl3ODV5V29FeVdIVmNUMnJfN2xKTm9hQ3RGSTFqeEhIVGtrU3c?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T17:35:02+00:00", "published_display": "17 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Factors Led to 20/20 Biolabs' Dramatic Stock Collapse", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQV2hRNkVtaTdFX1pCaGhwaDAwV0lXc0JxQm5YaEdXaEczRXJ5anlzNGMxYm5UNmg0ZjYtaWlrXzhBUjJkdnF2RW5IRzJCUnp4RncwbFBiN1BlSWZmYVU2Tnd0NWUyN2R4UEZDakp5RXpWZGZERkxKRTlwaFFqRVdob0xSaGl2ZzJId3dSZ0ZobjVwd0tqZXZz?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-16T10:02:25+00:00", "published_display": "16 Jul 2026 10:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of 20/20 Biolabs, Inc. \u2013 NASDAQ:AIDX", "summary": "This page displays the \"Price to earnings forward\" value for 20/20 Biolabs, Inc. (NASDAQ: AIDX). The content indicates that the value is currently absent or not provided. The page is sourced from TradingView and provides financial data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T09:41:48", "published_display": "27 Jun 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of 20/20 Biolabs, Inc. \u2013 NASDAQ:AIDX", "summary": "The article focuses on the \"Price to book forward\" metric for 20/20 Biolabs, Inc. (NASDAQ: AIDX). It appears to be a stub or a data point from a financial platform like TradingView, indicating a specific financial ratio for the company. The content primarily shows the title of th", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T18:11:10", "published_display": "25 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs, Inc. Actuals & Estimates (NASDAQ:AIDX)", "summary": "This article provides an overview of 20/20 Biolabs, Inc. (NASDAQ: AIDX) stock performance, financial estimates, and key company data. It includes details such as current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings reports, alon", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T17:11:41", "published_display": "25 Jun 2026 17:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of 20/20 Biolabs, Inc. \u2013 NASDAQ:AIDX", "summary": "This article focuses on the \"Price to sales forward\" financial metric for 20/20 Biolabs, Inc. (NASDAQ: AIDX). It appears to be a page from TradingView, displaying company financials and market data.", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T13:09:49", "published_display": "25 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX | 20/20 Biolabs, Inc. Common Executive Compensation", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBjSDd2TERibTVQMXIxdm9NeVIzR20zd000NEY4THhRTGM3ckRwWC1TYnFNdmxrN2NWLTVBUm51U3BVM2kxdnNDbl92V0liRC15TVpGLTFYbkdxMGM2akdzSkcxbUxObUhaZkx5VjBOQQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-25T10:25:09+00:00", "published_display": "25 Jun 2026 10:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs starts monthly webinars, with a OneTest discount for attendees", "summary": "20/20 BioLabs (Nasdaq: AIDX) has launched a monthly investor webinar series, with the inaugural session on July 1, 2026, at 12:00 p.m. ET. These 45-minute webinars will occur on the first Wednesday of each month to provide updates, direct access to management, and a promotional d", "url": "https://www.stocktitan.net/news/AIDX/20-20-bio-labs-announces-monthly-investor-webinar-series-to-be-held-u9z8szx0sb6n.html", "source_name": "Stock Titan", "published_at": "2026-06-24T20:41:13", "published_display": "24 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Large share authorization and new equity plan up for 20/20 Biolabs (AIDX) vote", "summary": "20/20 Biolabs, Inc. (AIDX) is proposing several key changes for stockholder approval at its August 18, 2026, virtual annual meeting, including electing six directors, ratifying its auditor, approving a major charter change to increase authorized common stock from 50 million to 50", "url": "https://www.stocktitan.net/sec-filings/AIDX/def-14a-20-20-biolabs-inc-definitive-proxy-statement-3bd75666f180.html", "source_name": "Stock Titan", "published_at": "2026-06-23T21:11:42", "published_display": "23 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month", "summary": "20/20 BioLabs, Inc. (Nasdaq: AIDX) has launched a new monthly investor webinar series to enhance transparency and communication with shareholders. The series will commence on July 1, 2026, and will be held on the first Wednesday of each month to provide updates on the company's p", "url": "https://www.globenewswire.com/news-release/2026/06/22/3315623/0/en/20-20-biolabs-announces-monthly-investor-webinar-series-to-be-held-on-the-first-wednesday-of-each-month.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T21:09:45", "published_display": "22 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Health Care Stocks Moving In Monday's Intraday Session - 20/20 Biolabs (NASDAQ:AIDX), Context Therapeu", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOUHBPdWh5THFqWGVPUTZDUEMyRVdwR2FDSHZiWi1YZDVGSUx6ci1zV2pocURadkpXanZlbXBUZHlFSUVnUFNfS3E2WER6alZqemp0UVVKQlFjcG5xZU5zMmwxSlJTRHZXTXFrYnUtVUd6Zzg2dlVSVHZ1ZXJBX2xuMmtiN1pzQS1Na0VDQVM5Mk1WVkRsZUtBNFhTaWFLRVloaGFXNWRLNkU0dEZGVnBnS2J3?oc=5", "source_name": "Benzinga", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices Specialty Stocks Q1 2026: Enovis Revenue Beat, Stock Down 12% - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOdnZ5WlFjVTNFcV9PbG5zY3FMcVg4Y0RvVklPdXJRbC01Y3BvWVRYNmphaXBHdU5HajktbnNkX2JCbU9HYzdON2NmTTgzNVZkU3ZkOG95RE9lRkRNQW90OUdqRFJUajIzQVFZSGMtYUxsVlUxUUZkNWdvNjMxby1aS1JkZXN4eGZEM0tiOTJubw?oc=5", "source_name": "IndexBox", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs (NASDAQ: AIDX) asks shareholders to raise authorized shares to 500M", "summary": "20/20 Biolabs (AIDX) is seeking shareholder approval to increase its authorized common stock from 50 million to 500 million shares at its 2026 Annual Meeting. This action aims to replenish the share pool for future issuance, including potential conversions of Series E preferred s", "url": "https://www.stocktitan.net/sec-filings/AIDX/pre-14a-20-20-biolabs-inc-preliminary-proxy-statement-83934dbfaf6d.html", "source_name": "Stock Titan", "published_at": "2026-06-01T20:10:30", "published_display": "01 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs, Inc. Files Form 8-K Announcing Amended and Restated Bylaws and Nasdaq Listing as Emerging Growth Company", "summary": "20/20 Biolabs, Inc. (Nasdaq: AIDX) has filed a Form 8-K announcing an amendment to its bylaws, reducing the quorum required for a shareholder meeting from a majority to one-third of outstanding shares. This change, approved on May 19, 2026, has significant implications for corpor", "url": "https://www.minichart.com.sg/2026/05/27/20-20-biolabs-inc-files-form-8-k-announcing-amended-and-restated-bylaws-and-nasdaq-listing-as-emerging-growth-company/", "source_name": "Minichart", "published_at": "2026-05-27T14:38:42", "published_display": "27 May 2026 14:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs, Inc. - Common Stock (Nasdaq:AIDX) Stock Quote", "summary": "This article provides a real-time stock quote for 20/20 Biolabs, Inc. (Nasdaq: AIDX), showing its current trading price, daily range, and recent performance metrics. It also includes a list of top news and press releases related to the company, covering financial results, new pro", "url": "https://markets.chroniclejournal.com/chroniclejournal/quote?Symbol=537%3A2578441753", "source_name": "The Chronicle-Journal", "published_at": "2026-05-27T12:38:42", "published_display": "27 May 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs (NASDAQ: AIDX) cuts quorum for shareholder meetings", "summary": "20/20 Biolabs, Inc. (NASDAQ: AIDX) has amended its bylaws to reduce the shareholder quorum requirement for stockholder meetings from a majority of shares outstanding to one-third. This change aims to facilitate the company's ability to conduct official business at meetings, espec", "url": "https://www.stocktitan.net/sec-filings/AIDX/8-k-20-20-biolabs-inc-reports-material-event-7eca8a73e300.html", "source_name": "Stock Titan", "published_at": "2026-05-27T09:19:40", "published_display": "27 May 2026 09:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX Price Today: 20/20 Biolabs, Inc. Stock Price, Quote & Chart | MEXC", "summary": "This article provides current stock price information for 20/20 Biolabs, Inc. (AIDX) on the NASDAQ, showing it trading at $1.01 with a 14.52% decrease. It details key market data, including market cap, volume, and recent price changes, along with a company overview and instructio", "url": "https://www.mexc.co/en-IN/stocks/aidx", "source_name": "MEXC Exchange", "published_at": "2026-05-24T07:10:07", "published_display": "24 May 2026 07:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand", "summary": "20/20 Biolabs, Inc. announced emergency planning to establish Ebola and Hantavirus testing in its CAP-accredited CLIA laboratory, should public health agencies require assistance. The company plans to leverage its experience from the COVID-19 pandemic, during which it processed o", "url": "https://www.sahmcapital.com/news/content/2020-biolabs-commences-emergency-planning-for-ebola-hantavirus-lab-testing-if-outbreak-creates-overflow-demand-2026-05-22", "source_name": "Sahm", "published_at": "2026-05-24T05:39:46", "published_display": "24 May 2026 05:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX - 20/20 Biolabs Inc Stock Price and Quote", "summary": "This page provides a detailed overview of 20/20 Biolabs Inc. (AIDX) stock, including its latest price, performance metrics, and key financial data. It also lists recent news and corporate filings, highlighting the company's activities in medical devices and its initiatives in tes", "url": "https://finviz.com/stock?t=AIDX", "source_name": "Finviz", "published_at": "2026-05-23T17:09:02", "published_display": "23 May 2026 17:09", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX Slides As 20/20 Biolabs Inc. Faces Heavy Selling", "summary": "20/20 Biolabs Inc. (AIDX) experienced a significant stock slide of -15.35% due to negative trial data and strong selling pressure. Analyst sentiment is negative, citing weak fundamentals, razor-thin gross profit, and a high-risk early-stage healthcare AI diagnostics position. The", "url": "https://www.timothysykes.com/news/2020biolabsinc-aidx-news-2026_05_23/", "source_name": "Timothy Sykes", "published_at": "2026-05-23T15:08:57", "published_display": "23 May 2026 15:08", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains 20/20 BIOLABS INC(AIDX.US) With Buy Rating, Maintains Target Price $5", "summary": "Maxim Group has reiterated its Buy rating for 20/20 BIOLABS INC (AIDX.US) and maintained its price target at $5. This indicates a continued positive outlook from the analyst firm for the company.", "url": "https://news.futunn.com/en/post/73544196/maxim-group-maintains-20-20-biolabs-inc-aidxus-with-buy", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-05-23T05:09:46", "published_display": "23 May 2026 05:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs stock surges on Ebola testing plans", "summary": "20/20 Biolabs Inc. (NASDAQ:AIDX) shares surged 16% in premarket trading after the company announced plans to develop Ebola and Hantavirus testing capabilities. The company is evaluating PCR test kits and existing equipment to meet potential demands, leveraging its experience from", "url": "https://www.investing.com/news/stock-market-news/2020-biolabs-stock-surges-on-ebola-testing-plans-93CH-4706645", "source_name": "Investing.com", "published_at": "2026-05-23T04:08:57", "published_display": "23 May 2026 04:08", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs (NASDAQ: AIDX) registers 10.105M shares; posts Q1 2026 results", "summary": "20/20 Biolabs (AIDX) filed a prospectus supplement to register 10.105 million shares for resale by certain stockholders and included its Form 10-Q for Q1 2026. The company reported a net loss of $2,174,836 for the quarter and identified material weaknesses in internal controls, w", "url": "https://www.stocktitan.net/sec-filings/AIDX/424b3-20-20-biolabs-inc-prospectus-filed-pursuant-to-rule-424-b-3-4d459502ef77.html", "source_name": "Stock Titan", "published_at": "2026-05-22T21:40:13", "published_display": "22 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "20/20 Biolabs Inc (AIDX:UR): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE1fYnNncFlsN3h0MWRSTTVVNUJQYmlFeVpVOTBOWjQtWE1QZkVDd3ZqeE5OcnJYMmIzZmJxSVMyamxUdExVM2ZpQjBRYzVCUm5DQTN6Qg?oc=5", "source_name": "BNN Bloomberg", "published_at": "2026-03-14T00:25:39+00:00", "published_display": "14 Mar 2026 00:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "20/20 Biolabs (AIDX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE82WExDZnotSURPSjIwZUtiNEtfSEhHSzVDcnZ6bC1uUU9sMFUwcjhxSkw3c1NRcXZheEZYdmY0ZkRFR19xdkNWYWlwSTNLa21rVVdPUWVYQzczZw?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-03T00:36:50+00:00", "published_display": "03 Mar 2026 00:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US stock market on the verge of largest loss today: Dow, S&P 500, Nasdaq 100 wiped out over 1.5% as losses", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "The Economic Times", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE13bjFzelpydHRjOUtIZFhTeGJFdkw5WEZlWlNHakNzbXh5aFRvbE5TNmZXZHp4ZkJlOF94eGw2dllyRGZIbDNDd0s3eHN3NElx?oc=5", "source_name": "CNN", "published_at": "2026-02-20T20:02:15+00:00", "published_display": "20 Feb 2026 20:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol \"AIDX\" Following 3 Consecutive Years of Sales Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE53UV9pdzI4TXJPQ3JnR2xod2g4OHpZcUFWM0ZzaVV4SWVGeF9NNF9NVHNtdHA5SGFZdkEySTRBeEVjSzRyYmQ3TW04dXhVcmhiSm1GQnhOYWJCMEg1aU9ld0J0WHhSRmJsSExjTXdickk0UkdzR055cE1JT1NIUEU?oc=5", "source_name": "Market source", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs begins trading on Nasdaq under AIDX ticker", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQTzFla0dpY1o1UUd2X2x0Qm9VYnhVNXZ4c0p0dHotQllVT0ZkTzJGSmwwQ0sxekVMSkJ1U3JqVWc2OUZfcE8ySFNlTmpjUVNyQXM0RHZ1dEJaVVFkU3RlRC1hUzFlc0tJVVdpcHk2bWVEZThLQzFpZ3JhYThPOHM0a3F5MzVYYkJZTmlpS05ROHdLZzJ6VnM5MlJZbmlOdFhwRVQwZnZCQUlCX3JGYXpSN01n?oc=5", "source_name": "Investing.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "USA Stocks: Research Stocks from USA Stock Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE0wLXFyOXhDVHFBamN6Mml0UVlLZTVGS1owdjRURUJsUU84YlM5bzFhb0RGclA4bDFVTE9MQzVJTnR1YUxQejhmQU9hNkJoalNLNHR3b0tR?oc=5", "source_name": "GuruFocus", "published_at": "2022-07-13T22:32:16+00:00", "published_display": "13 Jul 2022 22:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxORk9ENlh5SlJsMWUxNEQxVlpSRENmeGxhU0hUdE02bERwWWZRSEZTeWRKZ1BuREhJOUppdTVnV0VjZ0tibGRpa0lzR1h4OXJNM1ZQdjA1YXVJbkZnd3N6U2xGX3hjaFVESWp5RWpQN2tOVG96ZnpCMUhZd0hha3NMZ3Z0Z1pEbHNpM2ZVSEFQQUVIQjFVTGNUUmlFNXhBQ3pmWWl3ODV5V29FeVdIVmNUMnJfN2xKTm9hQ3RGSTFqeEhIVGtrU3c?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T17:35:02+00:00", "published_display": "17 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Factors Led to 20/20 Biolabs' Dramatic Stock Collapse", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQV2hRNkVtaTdFX1pCaGhwaDAwV0lXc0JxQm5YaEdXaEczRXJ5anlzNGMxYm5UNmg0ZjYtaWlrXzhBUjJkdnF2RW5IRzJCUnp4RncwbFBiN1BlSWZmYVU2Tnd0NWUyN2R4UEZDakp5RXpWZGZERkxKRTlwaFFqRVdob0xSaGl2ZzJId3dSZ0ZobjVwd0tqZXZz?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-16T10:02:25+00:00", "published_display": "16 Jul 2026 10:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of 20/20 Biolabs, Inc. \u2013 NASDAQ:AIDX", "summary": "This page displays the \"Price to earnings forward\" value for 20/20 Biolabs, Inc. (NASDAQ: AIDX). The content indicates that the value is currently absent or not provided. The page is sourced from TradingView and provides financial data for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T09:41:48", "published_display": "27 Jun 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of 20/20 Biolabs, Inc. \u2013 NASDAQ:AIDX", "summary": "The article focuses on the \"Price to book forward\" metric for 20/20 Biolabs, Inc. (NASDAQ: AIDX). It appears to be a stub or a data point from a financial platform like TradingView, indicating a specific financial ratio for the company. The content primarily shows the title of th", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T18:11:10", "published_display": "25 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs, Inc. Actuals & Estimates (NASDAQ:AIDX)", "summary": "This article provides an overview of 20/20 Biolabs, Inc. (NASDAQ: AIDX) stock performance, financial estimates, and key company data. It includes details such as current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings reports, alon", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T17:11:41", "published_display": "25 Jun 2026 17:11", "sentiment": "negative", "sentiment_pct": 40, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of 20/20 Biolabs, Inc. \u2013 NASDAQ:AIDX", "summary": "This article focuses on the \"Price to sales forward\" financial metric for 20/20 Biolabs, Inc. (NASDAQ: AIDX). It appears to be a page from TradingView, displaying company financials and market data.", "url": "https://www.tradingview.com/symbols/NASDAQ-AIDX/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T13:09:49", "published_display": "25 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX | 20/20 Biolabs, Inc. Common Executive Compensation", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFBjSDd2TERibTVQMXIxdm9NeVIzR20zd000NEY4THhRTGM3ckRwWC1TYnFNdmxrN2NWLTVBUm51U3BVM2kxdnNDbl92V0liRC15TVpGLTFYbkdxMGM2akdzSkcxbUxObUhaZkx5VjBOQQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-25T10:25:09+00:00", "published_display": "25 Jun 2026 10:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs starts monthly webinars, with a OneTest discount for attendees", "summary": "20/20 BioLabs (Nasdaq: AIDX) has launched a monthly investor webinar series, with the inaugural session on July 1, 2026, at 12:00 p.m. ET. These 45-minute webinars will occur on the first Wednesday of each month to provide updates, direct access to management, and a promotional d", "url": "https://www.stocktitan.net/news/AIDX/20-20-bio-labs-announces-monthly-investor-webinar-series-to-be-held-u9z8szx0sb6n.html", "source_name": "Stock Titan", "published_at": "2026-06-24T20:41:13", "published_display": "24 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Large share authorization and new equity plan up for 20/20 Biolabs (AIDX) vote", "summary": "20/20 Biolabs, Inc. (AIDX) is proposing several key changes for stockholder approval at its August 18, 2026, virtual annual meeting, including electing six directors, ratifying its auditor, approving a major charter change to increase authorized common stock from 50 million to 50", "url": "https://www.stocktitan.net/sec-filings/AIDX/def-14a-20-20-biolabs-inc-definitive-proxy-statement-3bd75666f180.html", "source_name": "Stock Titan", "published_at": "2026-06-23T21:11:42", "published_display": "23 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month", "summary": "20/20 BioLabs, Inc. (Nasdaq: AIDX) has launched a new monthly investor webinar series to enhance transparency and communication with shareholders. The series will commence on July 1, 2026, and will be held on the first Wednesday of each month to provide updates on the company's p", "url": "https://www.globenewswire.com/news-release/2026/06/22/3315623/0/en/20-20-biolabs-announces-monthly-investor-webinar-series-to-be-held-on-the-first-wednesday-of-each-month.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T21:09:45", "published_display": "22 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Health Care Stocks Moving In Monday's Intraday Session - 20/20 Biolabs (NASDAQ:AIDX), Context Therapeu", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOUHBPdWh5THFqWGVPUTZDUEMyRVdwR2FDSHZiWi1YZDVGSUx6ci1zV2pocURadkpXanZlbXBUZHlFSUVnUFNfS3E2WER6alZqemp0UVVKQlFjcG5xZU5zMmwxSlJTRHZXTXFrYnUtVUd6Zzg2dlVSVHZ1ZXJBX2xuMmtiN1pzQS1Na0VDQVM5Mk1WVkRsZUtBNFhTaWFLRVloaGFXNWRLNkU0dEZGVnBnS2J3?oc=5", "source_name": "Benzinga", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices Specialty Stocks Q1 2026: Enovis Revenue Beat, Stock Down 12% - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOdnZ5WlFjVTNFcV9PbG5zY3FMcVg4Y0RvVklPdXJRbC01Y3BvWVRYNmphaXBHdU5HajktbnNkX2JCbU9HYzdON2NmTTgzNVZkU3ZkOG95RE9lRkRNQW90OUdqRFJUajIzQVFZSGMtYUxsVlUxUUZkNWdvNjMxby1aS1JkZXN4eGZEM0tiOTJubw?oc=5", "source_name": "IndexBox", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs (NASDAQ: AIDX) asks shareholders to raise authorized shares to 500M", "summary": "20/20 Biolabs (AIDX) is seeking shareholder approval to increase its authorized common stock from 50 million to 500 million shares at its 2026 Annual Meeting. This action aims to replenish the share pool for future issuance, including potential conversions of Series E preferred s", "url": "https://www.stocktitan.net/sec-filings/AIDX/pre-14a-20-20-biolabs-inc-preliminary-proxy-statement-83934dbfaf6d.html", "source_name": "Stock Titan", "published_at": "2026-06-01T20:10:30", "published_display": "01 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs, Inc. Files Form 8-K Announcing Amended and Restated Bylaws and Nasdaq Listing as Emerging Growth Company", "summary": "20/20 Biolabs, Inc. (Nasdaq: AIDX) has filed a Form 8-K announcing an amendment to its bylaws, reducing the quorum required for a shareholder meeting from a majority to one-third of outstanding shares. This change, approved on May 19, 2026, has significant implications for corpor", "url": "https://www.minichart.com.sg/2026/05/27/20-20-biolabs-inc-files-form-8-k-announcing-amended-and-restated-bylaws-and-nasdaq-listing-as-emerging-growth-company/", "source_name": "Minichart", "published_at": "2026-05-27T14:38:42", "published_display": "27 May 2026 14:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs, Inc. - Common Stock (Nasdaq:AIDX) Stock Quote", "summary": "This article provides a real-time stock quote for 20/20 Biolabs, Inc. (Nasdaq: AIDX), showing its current trading price, daily range, and recent performance metrics. It also includes a list of top news and press releases related to the company, covering financial results, new pro", "url": "https://markets.chroniclejournal.com/chroniclejournal/quote?Symbol=537%3A2578441753", "source_name": "The Chronicle-Journal", "published_at": "2026-05-27T12:38:42", "published_display": "27 May 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs (NASDAQ: AIDX) cuts quorum for shareholder meetings", "summary": "20/20 Biolabs, Inc. (NASDAQ: AIDX) has amended its bylaws to reduce the shareholder quorum requirement for stockholder meetings from a majority of shares outstanding to one-third. This change aims to facilitate the company's ability to conduct official business at meetings, espec", "url": "https://www.stocktitan.net/sec-filings/AIDX/8-k-20-20-biolabs-inc-reports-material-event-7eca8a73e300.html", "source_name": "Stock Titan", "published_at": "2026-05-27T09:19:40", "published_display": "27 May 2026 09:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX Price Today: 20/20 Biolabs, Inc. Stock Price, Quote & Chart | MEXC", "summary": "This article provides current stock price information for 20/20 Biolabs, Inc. (AIDX) on the NASDAQ, showing it trading at $1.01 with a 14.52% decrease. It details key market data, including market cap, volume, and recent price changes, along with a company overview and instructio", "url": "https://www.mexc.co/en-IN/stocks/aidx", "source_name": "MEXC Exchange", "published_at": "2026-05-24T07:10:07", "published_display": "24 May 2026 07:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand", "summary": "20/20 Biolabs, Inc. announced emergency planning to establish Ebola and Hantavirus testing in its CAP-accredited CLIA laboratory, should public health agencies require assistance. The company plans to leverage its experience from the COVID-19 pandemic, during which it processed o", "url": "https://www.sahmcapital.com/news/content/2020-biolabs-commences-emergency-planning-for-ebola-hantavirus-lab-testing-if-outbreak-creates-overflow-demand-2026-05-22", "source_name": "Sahm", "published_at": "2026-05-24T05:39:46", "published_display": "24 May 2026 05:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX - 20/20 Biolabs Inc Stock Price and Quote", "summary": "This page provides a detailed overview of 20/20 Biolabs Inc. (AIDX) stock, including its latest price, performance metrics, and key financial data. It also lists recent news and corporate filings, highlighting the company's activities in medical devices and its initiatives in tes", "url": "https://finviz.com/stock?t=AIDX", "source_name": "Finviz", "published_at": "2026-05-23T17:09:02", "published_display": "23 May 2026 17:09", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIDX Slides As 20/20 Biolabs Inc. Faces Heavy Selling", "summary": "20/20 Biolabs Inc. (AIDX) experienced a significant stock slide of -15.35% due to negative trial data and strong selling pressure. Analyst sentiment is negative, citing weak fundamentals, razor-thin gross profit, and a high-risk early-stage healthcare AI diagnostics position. The", "url": "https://www.timothysykes.com/news/2020biolabsinc-aidx-news-2026_05_23/", "source_name": "Timothy Sykes", "published_at": "2026-05-23T15:08:57", "published_display": "23 May 2026 15:08", "sentiment": "negative", "sentiment_pct": 30, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains 20/20 BIOLABS INC(AIDX.US) With Buy Rating, Maintains Target Price $5", "summary": "Maxim Group has reiterated its Buy rating for 20/20 BIOLABS INC (AIDX.US) and maintained its price target at $5. This indicates a continued positive outlook from the analyst firm for the company.", "url": "https://news.futunn.com/en/post/73544196/maxim-group-maintains-20-20-biolabs-inc-aidxus-with-buy", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-05-23T05:09:46", "published_display": "23 May 2026 05:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs stock surges on Ebola testing plans", "summary": "20/20 Biolabs Inc. (NASDAQ:AIDX) shares surged 16% in premarket trading after the company announced plans to develop Ebola and Hantavirus testing capabilities. The company is evaluating PCR test kits and existing equipment to meet potential demands, leveraging its experience from", "url": "https://www.investing.com/news/stock-market-news/2020-biolabs-stock-surges-on-ebola-testing-plans-93CH-4706645", "source_name": "Investing.com", "published_at": "2026-05-23T04:08:57", "published_display": "23 May 2026 04:08", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs (NASDAQ: AIDX) registers 10.105M shares; posts Q1 2026 results", "summary": "20/20 Biolabs (AIDX) filed a prospectus supplement to register 10.105 million shares for resale by certain stockholders and included its Form 10-Q for Q1 2026. The company reported a net loss of $2,174,836 for the quarter and identified material weaknesses in internal controls, w", "url": "https://www.stocktitan.net/sec-filings/AIDX/424b3-20-20-biolabs-inc-prospectus-filed-pursuant-to-rule-424-b-3-4d459502ef77.html", "source_name": "Stock Titan", "published_at": "2026-05-22T21:40:13", "published_display": "22 May 2026 21:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs Inc (AIDX:UR): Stock Price, Quote and News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE1fYnNncFlsN3h0MWRSTTVVNUJQYmlFeVpVOTBOWjQtWE1QZkVDd3ZqeE5OcnJYMmIzZmJxSVMyamxUdExVM2ZpQjBRYzVCUm5DQTN6Qg?oc=5", "source_name": "BNN Bloomberg", "published_at": "2026-03-14T00:25:39+00:00", "published_display": "14 Mar 2026 00:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 Biolabs (AIDX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE82WExDZnotSURPSjIwZUtiNEtfSEhHSzVDcnZ6bC1uUU9sMFUwcjhxSkw3c1NRcXZheEZYdmY0ZkRFR19xdkNWYWlwSTNLa21rVVdPUWVYQzczZw?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-03T00:36:50+00:00", "published_display": "03 Mar 2026 00:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US stock market on the verge of largest loss today: Dow, S&P 500, Nasdaq 100 wiped out over 1.5% as losses", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "The Economic Times", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE13bjFzelpydHRjOUtIZFhTeGJFdkw5WEZlWlNHakNzbXh5aFRvbE5TNmZXZHp4ZkJlOF94eGw2dllyRGZIbDNDd0s3eHN3NElx?oc=5", "source_name": "CNN", "published_at": "2026-02-20T20:02:15+00:00", "published_display": "20 Feb 2026 20:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol \"AIDX\" Following 3 Consecutive Years of Sales Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE53UV9pdzI4TXJPQ3JnR2xod2g4OHpZcUFWM0ZzaVV4SWVGeF9NNF9NVHNtdHA5SGFZdkEySTRBeEVjSzRyYmQ3TW04dXhVcmhiSm1GQnhOYWJCMEg1aU9ld0J0WHhSRmJsSExjTXdickk0UkdzR055cE1JT1NIUEU?oc=5", "source_name": "Market source", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "20/20 BioLabs begins trading on Nasdaq under AIDX ticker", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQTzFla0dpY1o1UUd2X2x0Qm9VYnhVNXZ4c0p0dHotQllVT0ZkTzJGSmwwQ0sxekVMSkJ1U3JqVWc2OUZfcE8ySFNlTmpjUVNyQXM0RHZ1dEJaVVFkU3RlRC1hUzFlc0tJVVdpcHk2bWVEZThLQzFpZ3JhYThPOHM0a3F5MzVYYkJZTmlpS05ROHdLZzJ6VnM5MlJZbmlOdFhwRVQwZnZCQUlCX3JGYXpSN01n?oc=5", "source_name": "Investing.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "USA Stocks: Research Stocks from USA Stock Market", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVkFVX3lxTE0wLXFyOXhDVHFBamN6Mml0UVlLZTVGS1owdjRURUJsUU84YlM5bzFhb0RGclA4bDFVTE9MQzVJTnR1YUxQejhmQU9hNkJoalNLNHR3b0tR?oc=5", "source_name": "GuruFocus", "published_at": "2022-07-13T22:32:16+00:00", "published_display": "13 Jul 2022 22:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 90, "total_relevant": 47, "sentiment_summary": {"positive": 10, "negative": 5, "neutral": 32, "score": 52, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 12.05, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 11.77, "count": 22}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 0.59, "latest_week": "2026-07-10", "one_week_move": -4.2, "four_week_move": -38.8, "twelve_week_move": -66.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -72.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 21.0619, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-4.2% over one week, -38.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "Stock Titan", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "Barron's", "count": 3}, {"label": "StockStory", "count": 3}, {"label": "Investing.com", "count": 2}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "Kavout | AI", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 37}, {"label": "Industry context", "count": 10}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 22}, {"label": "Market update", "count": 20}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "37", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "6", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-4.2% over one week, -38.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings"}], "updated_at": "2026-07-18T02:28:06.418243+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}